免疫治疗新 ROR:通过单克隆抗体和 CAR NK 细胞靶向 ROR1 近端结构域治疗乳腺癌
A new immunotherapy ROR: Proximal ROR1 domain targeting breast cancer via monoclonal antibodies and CAR NK cells.
78.6分
★★★★☆
站内排序·非疗效
MODALITY HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
A new immunotherapy ROR: Proximal ROR1 domain targeting breast cancer via monoclonal antibodies and CAR NK cells.
Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy.
Immunotherapies for Breast Cancer: From Checkpoint Inhibition to Emerging Cellular Therapies.
MEMBER ACCOUNT
登录成功会直接打开下一页。